Literature DB >> 2647422

Influenza A pneumonitis in a patient infected with the human immunodeficiency virus (HIV).

J R Thurn1, K Henry.   

Abstract

Influenza A results in considerable morbidity, mortality and economic costs. Although immunoprophylaxis and chemoprophylaxis are targeted toward high-risk groups, persons with human immunodeficiency virus (HIV) infection have not been widely recognized as being at increased risk of influenza infection. We report a case of influenza A pneumonitis in a patient infected with HIV. The literature on influenza immunization of HIV-infected patients is reviewed and the implications for public health are discussed. Consideration should be given to influenza immunization and chemoprophylaxis in this enlarging population. Further investigation of the pathogenesis and epidemiology of influenza in HIV-infected patients is warranted.

Entities:  

Mesh:

Year:  1989        PMID: 2647422     DOI: 10.1378/chest.95.4.807

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  9 in total

Review 1.  Influenza susceptibility, severity, and shedding in HIV-infected adults: a review of the literature.

Authors:  Anandi N Sheth; Keri N Althoff; John T Brooks
Journal:  Clin Infect Dis       Date:  2011-01-15       Impact factor: 9.079

Review 2.  Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses.

Authors:  Ken M Kunisaki; Edward N Janoff
Journal:  Lancet Infect Dis       Date:  2009-08       Impact factor: 25.071

3.  Comparison of neutralizing and hemagglutination-inhibiting antibody responses to influenza A virus vaccination of human immunodeficiency virus-infected individuals.

Authors:  C A Benne; F P Kroon; M Harmsen; L Tavares; C A Kraaijeveld; J C De Jong
Journal:  Clin Diagn Lab Immunol       Date:  1998-01

Review 4.  Humoral immune response to influenza vaccination in patients from high risk groups.

Authors:  L B Brydak; M Machala
Journal:  Drugs       Date:  2000-07       Impact factor: 9.546

5.  Predictors of reported influenza vaccination in HIV-infected women in the United States, 2006-2007 and 2007-2008 seasons.

Authors:  Keri N Althoff; Kathryn Anastos; Kenrad E Nelson; David D Celentano; Gerald B Sharp; Ruth M Greenblatt; Audrey L French; Don J Diamond; Susan Holman; Mary Young; Stephen J Gange
Journal:  Prev Med       Date:  2010-03-18       Impact factor: 4.018

6.  Preventing secondary infections among HIV-positive persons.

Authors:  G A Filice; C Pomeroy
Journal:  Public Health Rep       Date:  1991 Sep-Oct       Impact factor: 2.792

7.  Duration of Influenza Virus Shedding Among HIV-Infected Adults in the cART Era, 2010-2011.

Authors:  Pragna Patel; Timothy Bush; E Milu Kojic; Edgar T Overton; Keith Henry; Nur Önen; Frank Rhame; Lois Conley; John T Brooks; Alicia Fry
Journal:  AIDS Res Hum Retroviruses       Date:  2016-06-13       Impact factor: 2.205

Review 8.  Community respiratory viruses in individuals with human immunodeficiency virus infection.

Authors:  J C King
Journal:  Am J Med       Date:  1997-03-17       Impact factor: 4.965

9.  Inequalities in the utilisation of maternal health Care in Rural India: Evidences from National Family Health Survey III & IV.

Authors:  Balhasan Ali; Shekhar Chauhan
Journal:  BMC Public Health       Date:  2020-03-20       Impact factor: 3.295

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.